Loading...

PE/Cyanine7 anti-mouse CD150 (SLAM) Antibody

Pricing & Availability
Clone
TC15-12F12.2 (See other available formats)
Regulatory Status
RUO
Other Names
Signaling Lymphocyte Activation Molecule (SLAM), IPO-3
Isotype
Rat IgG2a, λ
Ave. Rating
Submit a Review
Product Citations
publications
TC15-12F12_PECy7_2_102110
C57BL/6 mouse bone marrow cells were stained with CD150 (clone TC15-12F12.2) PE/Cyanine7 (filled histogram) or rat IgG2a PE/Cyanine7 isotype control (open histogram) (gated on lymphoid cell population).
  • TC15-12F12_PECy7_2_102110
    C57BL/6 mouse bone marrow cells were stained with CD150 (clone TC15-12F12.2) PE/Cyanine7 (filled histogram) or rat IgG2a PE/Cyanine7 isotype control (open histogram) (gated on lymphoid cell population).
  • TC15-12F12dot2_PECy7_957
    C57BL/6 mouse splenocytes were stained with CD150 (clone TC15-12F12.2) PE/Cyanine7 (filled histogram) or rat IgG2a PE/Cyanine7 isotype control (open histogram).
See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
115913 25 µg 90€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
115914 100 µg 249€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD150 is a 75-95 kD member of the immunoglobulin superfamily, also known as SLAM (signaling lymphocyte activation molecule) or IPO-3. CD150, a single chain type I transmembrane molecule, is expressed on thymocytes, T cell subsets, B cells, dendritic cells, and endothelial cells. The expression is upregulated upon activation. CD150 expression has been shown to be maintained on Th1 but not Th2 clones. T regulatory cells express a relatively high level of CD150. Antibodies against CD150 have been shown to augment IFN-γ production by Th1 cells, especially when co-stimulated through the TCR. CD150 associates with the src homology 2-domain-containing protein tyrosine phosphatase SHP-2, and this association is thought to be involved in signal transduction. In combination with CD48, CD150 is a useful marker for hematopoietic stem cell studies.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse SLAM-human IgG1 fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD150 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The TC15-12F12.2 antibody has been reported to enhance the production of IFN-? by Th1 cells stimulated through TCR. Additional reported applications (for the relevant formats) include: immunoprecipitaion17, enhancing IFN-? production by Th1 cells when stimulated with CD31, and inhibiting CD3 induced T cell proliferation6. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 115949 & 115950).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Castro AG, et al. 1999. J. Immunol. 163:5860. (FC, Costim, IP)
  2. Forsberg EC, et al. 2005. PLoS Genet. 1:e28. (FC)
  3. Terrazas LI, et al. 2005. Int. J. Parasitol. 35:1349. (FC)
  4. Cannons JL, et al. 2006. J. Exp. Med. 203:1551. (FC)
  5. Umemoto T, et al. 2006. J. Immunol. 177:7733. (FC)
  6. Jordan MA, et al. 2007. J. Immunol. 178:1618. (FC, Block) PubMed
  7. Jung Y, et al. 2007. Blood 110:82. PubMed
  8. Pimanda JE, et al. 2007. Proc. Natl. Acad. Sci. USA 104:840.
  9. Sugiyama T, et al. 2007. Proc. Natl. Acad. Sci. USA 104:175.
  10. Kim I, et al. 2006. Blood 108:737. PubMed
  11. Ema H, et al. 2006. Nat Protoc. 1:2979. PubMed
  12. Fraser ST, et al. 2007. Blood 109:4616. PubMed
  13. Jung Y, et al. 2008. Stem Cells. 26:2042. Pubmed
  14. Song J, et al. 2010. Blood 115:2592. PubMed
  15. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 43:149. (FC) PubMed
  16. Morita Y, et al. 2010. J. Exp Med. 207:1173. PubMed
  17. Talaei N, et al. 2015. J. Immunol. 195(10):4623. PubMed
Product Citations
  1. de Almeida MJ et al. 2017. Cell stem cell. 21(6):725-729 . PubMed
  2. Grinenko T, et al. 2018. Nat Commun. 9:1898. PubMed
  3. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  4. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  5. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  6. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  7. Tzelepis K, et al. 2018. Nat Commun. 9:5378. PubMed
  8. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  9. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  10. Gozdecka M, et al. 2018. Nat Genet. 50:883. PubMed
  11. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  12. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  13. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  14. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  15. Passaro D et al. 2017. Cancer cell. 32(3):324-341 . PubMed
  16. Sykes DB et al. 2016. Cell. 167(1):171-186 . PubMed
  17. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  18. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  19. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  20. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  21. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  22. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  23. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  24. Luchsinger LL, et al. 2020. Cell Stem Cell. 25(2):225-240. PubMed
  25. Viaud M, et al. 2020. Cell Reports. 30(10):3397-3410. PubMed
  26. de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
  27. Wilkinson AC, et al. 2020. Nature Protocols. 15(2):628-648.. PubMed
  28. Paubelle E, et al. 2020. Cell Reports. 30(3):739-754.e4.. PubMed
  29. Wilkinson AC, et al. 2019. Nature. 571:117. PubMed
  30. Kent D, et al. 2009. Blood. 113:6342. PubMed
  31. Halene S, et al. 2010. Blood. 116:1942. PubMed
  32. Jordan M, et al. 2011. J Immunol. 186:3953. PubMed
  33. Glotzbach J, et al. 2011. PLoS One. 6:e21211. PubMed
  34. Gustafsson K, et al. 2013. Exp Cell Res. 319:1852. PubMed
  35. Guo F, et al. 2013. Haematologica. 98:1353. PubMed
  36. Tober J, et al. 2013. Development. 140:3765. PubMed
  37. Gerhardt D, et al. 2014. Genes Dev. 28:576. PubMed
  38. Karamitros D, et al. 2015. Development. 142:70. PubMed
  39. Rimmelé P, et al. 2015. EMBO Rep. 16: 1164-1176. PubMed
  40. Xia P, et al. 2015. J Exp Med. 212: 2305 - 2321. PubMed
  41. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  42. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  43. Nestorowa S, et al. 2016. Blood. 128: e20 - e31. PubMed
  44. Muto T, et al. 2020. Nat Immunol. 1.246527778. PubMed
  45. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  46. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  47. Upadhaya S, et al. 2020. Cell Stem Cell. 27(2):336-345.e4. PubMed
  48. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  49. Ueda K, et al. 2021. Cancer Cell. 39(4):529-547.e7. PubMed
  50. Hormaechea-Agulla D, et al. 2021. Cell Stem Cell. . PubMed
  51. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  52. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  53. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  54. Chlon TM, et al. 2021. Cell Stem Cell. :. PubMed
  55. Liang R, et al. 2020. Cell Stem Cell. 359:26. PubMed
  56. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  57. Yu W, et al. 2020. J Clin Invest. . PubMed
  58. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  59. Florez MA, et al. 2020. Cell Rep. 33:108530. PubMed
  60. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  61. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  62. Yankova E, et al. 2021. Nature. 593:597. PubMed
  63. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  64. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  65. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  66. Young IC, et al. 2021. Cell Rep. 37:110036. PubMed
  67. Bonnet C, et al. 2021. iScience. 24:103399. PubMed
  68. Koide S, et al. 2022. iScience. 25:103603. PubMed
  69. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  70. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  71. Fast EM, et al. 2021. Elife. 10:. PubMed
  72. Eisele AS, et al. 2022. Elife. 11:. PubMed
  73. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  74. Yang T, et al. 2022. Nat Commun. 13:4464. PubMed
  75. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  76. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  77. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  78. Muto T, et al. 2022. Cell Stem Cell. 29:298. PubMed
  79. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  80. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  81. Qiu J, et al. 2022. STAR Protoc. 3:101828. PubMed
  82. Feng J, et al. 2022. Immunity. 55:405. PubMed
  83. Dickerson KM, et al. 2022. Blood Cancer Discov. 3:240. PubMed
  84. Gómez-Salinero JM, et al. 2022. Nat Cardiovasc Res. 1:882. PubMed
  85. Le DT, et al. 2023. iScience. 26:106059. PubMed
  86. Muto T, et al. 2023. Haematologica. . PubMed
RRID
AB_439796 (BioLegend Cat. No. 115913)
AB_439797 (BioLegend Cat. No. 115914)

Antigen Details

Structure
Ig superfamily, 75-95 kD
Distribution

Thymocytes, T cell subset, B lymphocytes, dendritic cells, endothelial cells

Function
B cell and dendritic cell costimulation
Ligand/Receptor
CD150
Cell Type
B cells, Dendritic cells, Endothelial cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Cocks BG, et al. 1995. Nature 376:260.
2. Punnonen J, et al. 1997. J. Exp. Med. 185:993.
3. Sidorenko SP, et al. 1993. J. Immunol. 151:4614.

Gene ID
27218 View all products for this Gene ID
UniProt
View information about CD150 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11.30.2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account